CORRECTING and REPLACING – Novocure to Report Third Quarter 2016 Financial Results
September 30 2016 - 12:39PM
In a press release issued under the same headline earlier
today by Novocure, Ltd. (Nasdaq:NVCR), please note that the first
paragraph should say "the three and nine months ended Sept.
30, 2016" rather than "the three and six months ended Sept.
30, 2016" as previously stated. The corrected release follows:
Novocure to Report Third Quarter 2016
Financial Results
Novocure (NASDAQ:NVCR) announced today that it will
report financial results for the third quarter 2016 on Wednesday,
Nov. 2, 2016, before the open of U.S.-based financial markets.
Novocure management will host a conference call and webcast to
discuss its financial results for the three and nine months
ended Sept. 30, 2016, at 8 a.m. EDT on Wednesday, Nov. 2, 2016.
The conference call can be accessed by dialing 877-726-5929 for
domestic callers and 530-379-4648 for international callers, using
the conference ID 76871474. The webcast can be accessed live from
the Investor Relations page of Novocure’s website,
www.novocure.com/investors, and will be available for replay for at
least 14 days following the call.
About NovocureNovocure is a commercial-stage
oncology company developing a proprietary therapy called Tumor
Treating Fields, or TTFields, for the treatment of solid tumor
cancers. Headquartered in Jersey, Novocure has U.S. operations in
Portsmouth, New Hampshire, Malvern, Pennsylvania, and New York
City. Additionally, the company has offices in Germany, Switzerland
and Japan, and a research center in Haifa, Israel. For additional
information about the company, please visit www.novocure.com or
follow us at www.twitter.com/novocure.
Media and Investor Contact:
Ashley Cordova
212-767-7558
acordova@novocure.com
NovoCure (NASDAQ:NVCR)
Historical Stock Chart
From Aug 2024 to Sep 2024
NovoCure (NASDAQ:NVCR)
Historical Stock Chart
From Sep 2023 to Sep 2024